Robert Dumas is a Staff Attorney at Cohen Milstein and a member of the Securities Litigation & Investor Protection Practice Group. In this role, Mr. Dumas is engaged in document discovery and review and in preparing the attorneys in deposing witnesses. Since joining the Firm in 2014, he has worked on some of the most important mortgage backed securities (MBS) litigations to emerge from the financial crisis. 

Prior to joining the Firm, Mr. Dumas practiced at a leading plaintiff firm, litigating securities fraud matters, and then later at a smaller plaintiff firm, where he helped litigate the In re IPO securities litigation, in which investors accused the leading investment banks of rigging IPOs during the 1990s tech bubble; after nearly a decade of legal wrangling, a $586 million settlement was reached. Earlier, he practiced at a leading intellectual property and trademark law firm, where he defended trademark matters for an international clothing manufacturer.

Currently, Mr. Dumas is helping litigate the following matters:

  • NovaStar MBS Litigation: MBS litigation alleging violations of the Securities Act, namely that Deutsche Bank Securities, Inc., RBS Securities, LLC and Wells Fargo Securities (formerly Wachovia Securities) bundled toxic mortgages into securities and then marketed and sold them to investors. Mr. Dumas is engaged in document discovery.

He helped successfully litigate the following notable matters:

  • HEMT MBS Litigation: $110 million settlement with Credit Suisse. Cohen Milstein was lead counsel in a case alleging Credit Suisse and its affiliates sold toxic securities to pension fund investors. Mr. Dumas was deeply involved in document discovery and working on motions, and he played a lead role in preparing the Rule 56.1 statement.

Mr. Dumas graduated from the State University of New York at Albany with a B.A. in History and received his J.D. from Cornell Law School. During law school, he served as an Editor of the Journal of Law and Public Policy.